Development of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serum.

Abstract

BACKGROUND Hepatitis B virus (HBV) poses a serious risk to human health and the hepatitis B surface antigen (HBsAg) is a popular biomarker in the diagnosis of HBV infection. A quantitative method with a high degree of accuracy, sensitivity and throughput is needed. METHODS A novel amplified luminescent proximity homogeneous assay (AlphaLISA) was developed… (More)
DOI: 10.1016/j.cca.2013.09.013

Topics

Cite this paper

@article{Liu2013DevelopmentOA, title={Development of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serum.}, author={Tiancai Liu and Tingwen Huang and Zhi-ning Dong and An He and Ming Li and Ying-song Wu and Wei-Wen Xu}, journal={Clinica chimica acta; international journal of clinical chemistry}, year={2013}, volume={426}, pages={139-44} }